
EU Commission Conditionally Approves EZMEKLY
European Commission Grants Conditional Approval of EZMEKLY for Treatment of NF1-Associated Plexiform Neurofibromas in Adults and Children Merck, a global leader in science and technology, announced that the European Commission (EC) has granted conditional marketing authorization for EZMEKLY® (mirdametinib), a…












